pasireotide
Showing 1 - 25 of 27
Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)
Withdrawn
- Gastro-enteropancreatic Neuroendocrine Tumor
- Pasireotide
- Diazoxide
- (no location specified)
Feb 17, 2022
Enterostomy Trial in France (Pasireotide, Placebo)
Completed
- Enterostomy
- Pasireotide
- Placebo
-
Amiens, France
- +13 more
Mar 23, 2022
Hematological Malignancies Trial in Boston, Durham (Pasireotide)
Completed
- Hematological Malignancies
- Pasireotide
-
Boston, Massachusetts
- +1 more
Oct 19, 2021
Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)
Active, not recruiting
- Cushing's Disease
- +8 more
- Pasireotide
- Cabergoline
-
La Jolla, California
- +93 more
May 19, 2022
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- docetaxel
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 2, 2021
Hepatic Cirrhosis, Alcoholism Trial in Worldwide (Pasireotide)
Completed
- Hepatic Cirrhosis
- Alcoholism
- Pasireotide
-
Richmond, Virginia
- +3 more
Dec 17, 2020
Pancreatic Fistula, Pancreatic Tumors Trial in Helsinki (Hydrocortisone, Pasireotide)
Active, not recruiting
- Pancreatic Fistula
- Pancreatic Neoplasms
- Hydrocortisone
- Pasireotide
-
Helsinki, FinlandHelsinki University Central Hospital
Aug 21, 2020
Carcinoid Tumor, Acromegaly Trial in Worldwide (Pasireotide)
Completed
- Carcinoid Tumor
- Acromegaly
- Pasireotide
-
Los Angeles, California
- +16 more
Dec 17, 2020
Neuroendocrine Tumors Trial in Atlanta (Pasireotide, Sir-sphere Radioembolization, Everolimus)
Completed
- Neuroendocrine Tumors
- Pasireotide
- +2 more
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Oct 16, 2018
Castrate Resistant Prostate Cancer, Chemo Naive Prostate Cancer, Prostate Cancer Trial in New Haven, Philadelphia (Pasireotide,
Terminated
- Castrate Resistant Prostate Cancer
- +2 more
- Pasireotide
- +2 more
-
New Haven, Connecticut
- +1 more
Apr 23, 2018
Ectopic ACTH Syndrome Trial in Los Angeles (Pasireotide)
Withdrawn
- Ectopic ACTH Syndrome
- Pasireotide
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 24, 2018
Breast Cancer Trial in Paris, Villejuif (PASIREOTIDE, PLACEBO)
Completed
- Breast Cancer
- PASIREOTIDE
- PLACEBO
-
Paris, France
- +1 more
Jan 24, 2017
Nelson Syndrome Trial in United Kingdom (Pasireotide)
Terminated
- Nelson Syndrome
- Pasireotide
-
London, United Kingdom
- +3 more
Nov 1, 2016
Acromegaly Trial in Worldwide (Pasireotide, Octreotide)
Non-functioning Pituitary Adenomas, Prolactinomas Trial in Rio de Janeiro (Pasireotide, cabergoline)
Completed
- Non-functioning Pituitary Adenomas
- Prolactinomas
- Pasireotide
- cabergoline
-
Rio de Janeiro, RJ, BrazilEndocrinology Section - Hospital Universitário Clementino Fraga
Jul 21, 2016
Advanced Adult Hepatocellular Carcinoma Trial in Tampa, Chapel Hill, Winston-Salem (Everolimus, Pasireotide)
Completed
- Advanced Adult Hepatocellular Carcinoma
- Everolimus
- Pasireotide
-
Tampa, Florida
- +2 more
Mar 8, 2016
Angiodysplasia Trial in Paris (Pasireotide, Placebo)
Completed
- Angiodysplasia
- Pasireotide
- Placebo
-
Paris, FranceSociété Française d'Endoscopie Digestive (SFED)
Dec 4, 2015
Hyperglycemia Trial in San Diego (pasireotide)
Completed
- Hyperglycemia
- pasireotide
-
San Diego, CaliforniaCMR Center for Metabolic Research VASDHS
Dec 23, 2014
Postoperative Dumping Syndrome Trial in Leuven (Pasireotide, Placebo)
Completed
- Postoperative Dumping Syndrome
- Pasireotide
- Placebo
-
Leuven, Vlaams-Brabant, BelgiumUniversity Hospitals Leuven
Jul 4, 2013